ShareHope Medicine Co., Ltd. (TPEX:8403)
19.30
-0.20 (-1.03%)
Jul 17, 2026, 1:30 PM CST
ShareHope Medicine Market Cap
ShareHope Medicine has a market cap or net worth of 2.66 billion as of July 17, 2026. Its market cap has decreased by -25.63% in one year.
Market Cap
2.66B
Enterprise Value
3.31B
Revenue
4.38B
Ranking
n/a
PE Ratio
20.75
Stock Price
19.30
ChartMarket Cap Chart
Since December 24, 2008, ShareHope Medicine's market cap has increased from 525.00M to 2.66B, an increase of 405.99%. That is a compound annual growth rate of 9.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.66B | -17.34% |
| Dec 31, 2025 | 3.21B | -15.31% |
| Dec 31, 2024 | 3.79B | -8.49% |
| Dec 29, 2023 | 4.15B | 2.20% |
| Dec 30, 2022 | 4.06B | 31.44% |
| Dec 30, 2021 | 3.09B | -18.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 519.42B |
| Caliway Biopharmaceuticals | 175.09B |
| Pell Bio-Med Technology | 70.62B |
| Heron Neutron Medical | 68.90B |
| Great Novel Therapeutics Biotech & Medicals | 2.85B |
| Intech Biopharm | 2.77B |
| Maywufa Company | 2.75B |
| GlycoNex Incorporation | 2.69B |